Qualification: Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity.
Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. should be assessed against Kaal's source-bound claim that The IEO reinserts an intermediary into token offerings: the exchange screens the offering and the issuer no longer interacts with investors directly, reversing the direct issuer to investor structure of the ICO. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.
Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.
Holds when
Current debate
Scholarly basis
Evidence and mapping
Topics
Provenance
Verify